Forge Therapeutics and Active Motif to Collaborate on Epigenetic Research and Drug Discovery: Goal to advance ‘drugability’ of Jumonji KDMs

San Diego, Calif., March 28, 2016 – Forge Therapeutics, Inc., [...]

2016-04-04T00:24:26-07:0004.04.2016|Press Releases|

Forge Therapeutics Co-Founder to Showcase Thought Leadership in Metalloenzymes at the 251st American Chemical Society National Meeting

San Diego, Calif., March 10, 2016 – Forge Therapeutics, Inc., [...]

2016-03-10T20:13:56-08:0003.10.2016|Press Releases|
Go to Top